AngioDynamics, Inc. (ANGO)
11.98
-0.44
(-3.50%)
USD |
NASDAQ |
Nov 12, 16:00
11.98
-0.01
(-0.08%)
Pre-Market: 20:00
AngioDynamics Enterprise Value : 485.22M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 485.22M |
| November 11, 2026 | 503.68M |
| November 10, 2026 | 488.83M |
| November 09, 2026 | 490.95M |
| November 06, 2026 | 474.40M |
| November 05, 2026 | 477.80M |
| November 04, 2026 | 496.46M |
| November 03, 2026 | 474.40M |
| November 02, 2026 | 475.68M |
| October 30, 2026 | 485.43M |
| October 29, 2026 | 500.71M |
| October 28, 2026 | 491.37M |
| October 27, 2026 | 496.89M |
| October 26, 2026 | 493.07M |
| October 23, 2026 | 501.34M |
| October 22, 2026 | 486.71M |
| October 21, 2026 | 481.19M |
| October 20, 2026 | 477.80M |
| October 19, 2026 | 459.98M |
| October 16, 2026 | 453.62M |
| October 15, 2026 | 468.04M |
| October 14, 2026 | 445.56M |
| October 13, 2026 | 439.19M |
| October 12, 2026 | 460.40M |
| October 09, 2026 | 465.50M |
| Date | Value |
|---|---|
| October 08, 2026 | 453.19M |
| October 07, 2026 | 578.77M |
| October 06, 2026 | 588.53M |
| October 05, 2026 | 636.04M |
| October 02, 2026 | 617.80M |
| October 01, 2026 | 618.22M |
| September 30, 2026 | 629.25M |
| September 29, 2026 | 638.59M |
| September 28, 2026 | 636.04M |
| September 25, 2026 | 633.92M |
| September 24, 2026 | 625.01M |
| September 23, 2026 | 634.77M |
| September 22, 2026 | 641.56M |
| September 21, 2026 | 630.95M |
| September 18, 2026 | 631.80M |
| September 17, 2026 | 628.83M |
| September 16, 2026 | 632.65M |
| September 15, 2026 | 641.98M |
| September 14, 2026 | 634.77M |
| September 11, 2026 | 624.59M |
| September 10, 2026 | 623.31M |
| September 09, 2026 | 626.71M |
| September 08, 2026 | 622.47M |
| September 04, 2026 | 621.62M |
| September 03, 2026 | 633.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.182B |
| Abbott Laboratories | 213.21B |
| Alphatec Holdings, Inc. | 1.621B |
| AtriCure, Inc. | 2.760B |
| Baxter International, Inc. | 19.33B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.097M |
| Revenue (Quarterly) | 80.92M |
| Total Expenses (Quarterly) | 88.01M |
| EPS Diluted (Quarterly) | -0.1689 |
| Gross Profit Margin (Quarterly) | 56.00% |
| Profit Margin (Quarterly) | -8.77% |
| Earnings Yield | -6.59% |
| Normalized Earnings Yield | -4.280 |